Skip to main content
NCBI home page
Nucleic Acids Research logoLink to Nucleic Acids Research
. 1997 May 1;25(9):1836–1845. doi: 10.1093/nar/25.9.1836

Mechanistic analyses of site-specific degradation in DNA-RNA hybrids by prototypic DNA cleavers.

M Bansal 1, J S Lee 1, J Stubbe 1, J W Kozarich 1
PMCID: PMC146669  PMID: 9108169

Abstract

Bleomycin (BLM) binding and chemistry are apparently sensitive to differences in nucleic acid conformation and could conceivably be developed as a probe for sequence-dependent elements of conformation. We report on the development of a new methodology to synthesize heterogeneous DNA-RNA hybrids of defined sequence and present the results of our comparative studies on the cleavage of DNA and DNA-RNA hybrids by four drugs: BLM, neocarzinostatin and esperamicins A1 and C. In the case of BLM with duplex DNA, purine-pyrimidine steps such as GT and GC, are consistently hit, as previously observed. However, in heterogeneous sequence hybrids, not all GC sites are recognized by the drug, although all GT sites are. Suppressed GC sites are consistently flanked by pyrimidines on both the 3' and 5' sides, suggesting that the BLM binding site in hybrids spans at least four bases. Kinetic isotope studies with specifically deuterated substrates (kH/kD = 1.2-4.0) and the effect of oxygen on the product profile are presented in support of a mechanism consistent with 4'-hydrogen abstraction in hybrids. The powerful double-labeled probe technique was extended to study the mechanism of action of other DNA degrading drugs on DNA-RNA hybrids. For neocarzinostatin, the sequence specificity lies in the AT-rich region for hybrids and is similar to that of DNA, however, the overall cleavage pattern for the hybrid is significantly different from that for the same sequence of DNA. In the hybrid, a stretch of AT residues is essential and the A sites are damaged to a greater extent than they are in DNA. However, no kinetic isotope effects are observed and, based on the product profile, the mechanism of degradation of the DNA strand of hybrids seems to be limited to abstraction of the 5'-hydrogen. For esperamicin A1, damage on the DNA strand of hybrids occurs exclusively via 5'-hydrogen abstraction in a non-rate determining step and primarily at A and T sites. Esperamicin C behaves similarly, exhibiting no isotope effects at 1', 4' and 5' positions. Overall, the differences observed in site-specific cleavage between the two substrates is proposed to be a result of conformational differences between the DNA strand of duplex DNA and DNA-RNA hybrids.

Full Text

The Full Text of this article is available as a PDF (220.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Absalon M. J., Krishnamoorthy C. R., McGall G., Kozarich J. W., Stubbe J. Bleomycin mediated degradation of DNA-RNA hybrids does not involve C-1' chemistry. Nucleic Acids Res. 1992 Aug 25;20(16):4179–4185. doi: 10.1093/nar/20.16.4179. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Ajmera S., Wu J. C., Worth L., Jr, Rabow L. E., Stubbe J., Kozarich J. W. DNA degradation by bleomycin: evidence for 2'R-proton abstraction and for C-O bond cleavage accompanying base propenal formation. Biochemistry. 1986 Oct 21;25(21):6586–6592. doi: 10.1021/bi00369a037. [DOI] [PubMed] [Google Scholar]
  3. Arnott S., Chandrasekaran R., Millane R. P., Park H. S. DNA-RNA hybrid secondary structures. J Mol Biol. 1986 Apr 20;188(4):631–640. doi: 10.1016/s0022-2836(86)80011-0. [DOI] [PubMed] [Google Scholar]
  4. Bansal M., Stubbe J., Kozarich J. W. Effects of hypoxanthine substitution on bleomycin-mediated DNA strand degradation in DNA-RNA hybrids. Nucleic Acids Res. 1997 May 1;25(9):1846–1853. doi: 10.1093/nar/25.9.1846. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Burger R. M., Peisach J., Horwitz S. B. Activated bleomycin. A transient complex of drug, iron, and oxygen that degrades DNA. J Biol Chem. 1981 Nov 25;256(22):11636–11644. [PubMed] [Google Scholar]
  6. Carter B. J., de Vroom E., Long E. C., van der Marel G. A., van Boom J. H., Hecht S. M. Site-specific cleavage of RNA by Fe(II).bleomycin. Proc Natl Acad Sci U S A. 1990 Dec;87(23):9373–9377. doi: 10.1073/pnas.87.23.9373. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. D'Andrea A. D., Haseltine W. A. Sequence specific cleavage of DNA by the antitumor antibiotics neocarzinostatin and bleomycin. Proc Natl Acad Sci U S A. 1978 Aug;75(8):3608–3612. doi: 10.1073/pnas.75.8.3608. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Haidle C. W., Bearden J., Jr Effect of bleomycin on an RNA-DNA hybrid. Biochem Biophys Res Commun. 1975 Aug 4;65(3):815–821. doi: 10.1016/s0006-291x(75)80458-x. [DOI] [PubMed] [Google Scholar]
  9. Kappen L. S., Goldberg I. H. Deoxyribonucleic acid damage by neocarzinostatin chromophore: strand breaks generated by selective oxidation of C-5' of deoxyribose. Biochemistry. 1983 Oct 11;22(21):4872–4878. doi: 10.1021/bi00290a002. [DOI] [PubMed] [Google Scholar]
  10. Kappen L. S., Goldberg I. H., Frank B. L., Worth L., Jr, Christner D. F., Kozarich J. W., Stubbe J. Neocarzinostatin-induced hydrogen atom abstraction from C-4' and C-5' of the T residue at a d(GT) step in oligonucleotides: shuttling between deoxyribose attack sites based on isotope selection effects. Biochemistry. 1991 Feb 26;30(8):2034–2042. doi: 10.1021/bi00222a005. [DOI] [PubMed] [Google Scholar]
  11. Kappen L. S., Goldberg I. H., Liesch J. M. Identification of thymidine-5'-aldehyde at DNA strand breaks induced by neocarzinostatin chromophore. Proc Natl Acad Sci U S A. 1982 Feb;79(3):744–748. doi: 10.1073/pnas.79.3.744. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Kozarich J. W., Worth L., Jr, Frank B. L., Christner D. F., Vanderwall D. E., Stubbe J. Sequence-specific isotope effects on the cleavage of DNA by bleomycin. Science. 1989 Sep 22;245(4924):1396–1399. doi: 10.1126/science.2476851. [DOI] [PubMed] [Google Scholar]
  13. Kuwahara J., Sugiura Y. Sequence-specific recognition and cleavage of DNA by metallobleomycin: minor groove binding and possible interaction mode. Proc Natl Acad Sci U S A. 1988 Apr;85(8):2459–2463. doi: 10.1073/pnas.85.8.2459. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Long B. H., Golik J., Forenza S., Ward B., Rehfuss R., Dabrowiak J. C., Catino J. J., Musial S. T., Brookshire K. W., Doyle T. W. Esperamicins, a class of potent antitumor antibiotics: mechanism of action. Proc Natl Acad Sci U S A. 1989 Jan;86(1):2–6. doi: 10.1073/pnas.86.1.2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Lu M., Guo Q., Krishnan B., Golik J., Rosenberg I. E., Doyle T. W., Kallenbach N. R. Determination of DNA cleavage specificity by esperamicins. J Biomol Struct Dyn. 1991 Oct;9(2):285–298. doi: 10.1080/07391102.1991.10507913. [DOI] [PubMed] [Google Scholar]
  16. Magliozzo R. S., Peisach J., Ciriolo M. R. Transfer RNA is cleaved by activated bleomycin. Mol Pharmacol. 1989 Apr;35(4):428–432. [PubMed] [Google Scholar]
  17. Maxam A. M., Gilbert W. Sequencing end-labeled DNA with base-specific chemical cleavages. Methods Enzymol. 1980;65(1):499–560. doi: 10.1016/s0076-6879(80)65059-9. [DOI] [PubMed] [Google Scholar]
  18. Mei H. Y., Barton J. K. Tris(tetramethylphenanthroline)ruthenium(II): a chiral probe that cleaves A-DNA conformations. Proc Natl Acad Sci U S A. 1988 Mar;85(5):1339–1343. doi: 10.1073/pnas.85.5.1339. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Morgan M. A., Hecht S. M. Iron(II) bleomycin-mediated degradation of a DNA-RNA heteroduplex. Biochemistry. 1994 Aug 30;33(34):10286–10293. doi: 10.1021/bi00200a008. [DOI] [PubMed] [Google Scholar]
  20. Murray V., Martin R. F. Comparison of the sequence specificity of bleomycin cleavage in two slightly different DNA sequences. Nucleic Acids Res. 1985 Mar 11;13(5):1467–1481. doi: 10.1093/nar/13.5.1467. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Poon R., Beerman T. A., Goldberg I. H. Characterization of DNA strand breakage in vitro by the antitumor protein neocarzinostatin. Biochemistry. 1977 Feb 8;16(3):486–493. doi: 10.1021/bi00622a023. [DOI] [PubMed] [Google Scholar]
  22. Salazar M., Fedoroff O. Y., Miller J. M., Ribeiro N. S., Reid B. R. The DNA strand in DNA.RNA hybrid duplexes is neither B-form nor A-form in solution. Biochemistry. 1993 Apr 27;32(16):4207–4215. doi: 10.1021/bi00067a007. [DOI] [PubMed] [Google Scholar]
  23. Sausville E. A., Peisach J., Horwitz S. B. A role for ferrous ion and oxygen in the degradation of DNA by bleomycin. Biochem Biophys Res Commun. 1976 Dec 6;73(3):814–822. doi: 10.1016/0006-291x(76)90882-2. [DOI] [PubMed] [Google Scholar]
  24. Sausville E. A., Stein R. W., Peisach J., Horwitz S. B. Properties and products of the degradation of DNA by bleomycin and iron(II). Biochemistry. 1978 Jul 11;17(14):2746–2754. doi: 10.1021/bi00607a008. [DOI] [PubMed] [Google Scholar]
  25. Sugiura Y., Uesawa Y., Takahashi Y., Kuwahara J., Golik J., Doyle T. W. Nucleotide-specific cleavage and minor-groove interaction of DNA with esperamicin antitumor antibiotics. Proc Natl Acad Sci U S A. 1989 Oct;86(20):7672–7676. doi: 10.1073/pnas.86.20.7672. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Takeshita M., Grollman A. P., Ohtsubo E., Ohtsubo H. Interaction of bleomycin with DNA. Proc Natl Acad Sci U S A. 1978 Dec;75(12):5983–5987. doi: 10.1073/pnas.75.12.5983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Umezawa H., Maeda K., Takeuchi T., Okami Y. New antibiotics, bleomycin A and B. J Antibiot (Tokyo) 1966 Sep;19(5):200–209. [PubMed] [Google Scholar]
  28. Worth L., Jr, Frank B. L., Christner D. F., Absalon M. J., Stubbe J., Kozarich J. W. Isotope effects on the cleavage of DNA by bleomycin: mechanism and modulation. Biochemistry. 1993 Mar 16;32(10):2601–2609. doi: 10.1021/bi00061a018. [DOI] [PubMed] [Google Scholar]
  29. Wu J. C., Kozarich J. W., Stubbe J. Mechanism of bleomycin: evidence for a rate-determining 4'-hydrogen abstraction from poly(dA-dU) associated with the formation of both free base and base propenal. Biochemistry. 1985 Dec 17;24(26):7562–7568. doi: 10.1021/bi00347a009. [DOI] [PubMed] [Google Scholar]
  30. Wu J. C., Kozarich J. W., Stubbe J. The mechanism of free base formation from DNA by bleomycin. A proposal based on site specific tritium release from Poly(dA.dU). J Biol Chem. 1983 Apr 25;258(8):4694–4697. [PubMed] [Google Scholar]
  31. Wu J. C., Stubbe J., Kozarich J. W. Mechanism of bleomycin: evidence for 4'-ketone formation in poly(dA-dU) associated exclusively with free base release. Biochemistry. 1985 Dec 17;24(26):7569–7573. doi: 10.1021/bi00347a010. [DOI] [PubMed] [Google Scholar]
  32. Yu L., Goldberg I. H., Dedon P. C. Enediyne-mediated DNA damage in nuclei is modulated at the level of the nucleosome. J Biol Chem. 1994 Feb 11;269(6):4144–4151. [PubMed] [Google Scholar]
  33. Zeng X., Xi Z., Kappen L. S., Tan W., Goldberg I. H. Double-stranded damage of DNA.RNA hybrids by neocarzinostatin chromophore: selective C-1' chemistry on the RNA strand. Biochemistry. 1995 Sep 26;34(38):12435–12444. doi: 10.1021/bi00038a042. [DOI] [PubMed] [Google Scholar]

Articles from Nucleic Acids Research are provided here courtesy of Oxford University Press

RESOURCES